{"name":"RyCarma Therapeutics, Inc.","slug":"rycarma-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE5qMEtCTHRtVWZGUUVub29rY2wta0pseUxSaHVWV3dGdVV3X2JJNFMwUXlvc2djQndwNTI0Z0hoc0dLRjA5QmYtWmxQS1hJcktJWk1lYlZ6UU9Qb0swanRXWEtIWFhFNDNsQ1ZGOEcwcE5ZZTBBYjg3UllzUQ?oc=5","date":"2026-02-18","type":"pipeline","source":"pharmaphorum","summary":"Changing Faces: Board of Directors, January 2026 - pharmaphorum","headline":"Changing Faces: Board of Directors, January 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPWVR6NWxoNUtQVGlGWjRpclR6dVBJWkdVUHpuUlNHU0xsN2duelM0Vk1OUmhYWGtXSUFfZFh5Y1FSUUF5Sk9ScGIwUHFNTmVzbW56c2lSUVUwN05RS0JMMmY2ZnNDZjE0SFhDWEJZVjJlQXUwX2VSUWN1LWJDZmVXT3dpai1fUEhZZ0k3Q2FWWF9zMEg3bnRTRVVybmhRYjRqblNtNWQtSlQ?oc=5","date":"2025-04-04","type":"trial","source":"Endpoints News","summary":"Novo Nordisk adjusts its leadership team; Dyne alums migrate to Crescent Biopharma - Endpoints News","headline":"Novo Nordisk adjusts its leadership team; Dyne alums migrate to Crescent Biopharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOSzI4WkJoRWxnVlZ2TWxPR2lqYUc1Y0psN3FqMmNZZXloWEQ1Y1VFTEpwTXlWYjNfbEROazduaGE1YXFBSGxuNnZhWmRSVFc1a2k0MXBSYzJWaEZCT1Y1aXk0djJFaWxhaDhHY0h5ekpHTUpKREJfVWd3Tm9KdEo4QUJhcUdmUHQ4NzhVTA?oc=5","date":"2025-04-04","type":"regulatory","source":"Fierce Biotech","summary":"Chutes & Ladders—FDA rocked by leadership shake-ups - Fierce Biotech","headline":"Chutes & Ladders—FDA rocked by leadership shake-ups","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNOEtZMERJSFE4ODJEeV9yVjVWajk4VUoxWXhEcFBtdUtLZjJRcFdNV3Vna3BNTkgzUjdpUkhLS0gzTmlVLUN4Q1RXVUZpMjJFWHYzSlZ0RFpXeFg2bmp3Rm5UdjVsUVU3V3puX3BGTzJLMkVaYk9vNnNhUFhpRGE5em5neUZBM3dTRUZTWGVNcm8yd1ZMclNEVQ?oc=5","date":"2025-01-07","type":"pipeline","source":"Fierce Pharma","summary":"Letting go of Armgo: Biotech rebrands as RyCarma Therapeutics - Fierce Pharma","headline":"Letting go of Armgo: Biotech rebrands as RyCarma Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxOSG1kVXh0U0UwUG9GdmVScUlodHN2V1h1LXBiYzJyeXBpbTRWSGRxQ29Ed1RBWUpUQUxNZjlCMjVFeVBWcXJfM0N4Uk5teWR5bXVMa1J6Qlk4T0E3Uk1ZenVva2lkMTZ3Z0lIeUE1OVBhMzMwY2Z5ZGRObDBEZmpWem9Ea1JXOGFXTGlBQnNFNUQ0ZzRjNVV6djh3b0VlMno0bDJIeUt4VENmc0RWTTR3dlZRcnRSc3g5d2V2RGRaY3FzdHNKSUU5THFiVkZpSW1GSEZEUnVhLWNiMW5KNjM3ekJIaF9FakU5ZXFZ?oc=5","date":"2025-01-07","type":"pipeline","source":"Business Wire","summary":"RyCarma Therapeutics Announces New Leadership and Company Name, Introduces Program in Heart Failure - Business Wire","headline":"RyCarma Therapeutics Announces New Leadership and Company Name, Introduces Program in Heart Failure","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}